Tekla Life Sciences Investors Stock Forecast
Green day on Monday for Tekla Life Sciences Investors stock after gaining 1.48%
(Updated on Apr 22, 2024)
The Tekla Life Sciences Investors stock price gained 1.48% on the last trading day (Monday, 22nd Apr 2024), rising from $12.80 to $12.99. During the last trading day the stock fluctuated 1.28% from a day low at $12.85 to a day high of $13.01. The price has fallen in 5 of the last 10 days and is down by -1.81% for this period. Volume fell on the last day by -21 thousand shares and in total, 73 thousand shares were bought and sold for approximately $950.56 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the middle of a falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -7.11% during the next 3 months and, with a 90% probability hold a price between $11.83 and $12.44 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
HQL Signals & Forecast
There are mixed signals in the stock today. The Tekla Life Sciences Investors stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $13.38. On a fall, the stock will find some support from the short-term average at $12.88. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not. A buy signal was issued from a pivot bottom point on Wednesday, April 17, 2024, and so far it has risen 1.56%. Further rise is indicated until a new top pivot has been found.
Support, Risk & Stop-loss for Tekla Life Sciences Investors stock
Tekla Life Sciences Investors finds support from accumulated volume at $12.98 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
In general the stock tends to have controlled movements and therefore the general risk is considered low. However, be aware of low or falling volume and make sure to keep an eye on the stock. During the last day, the stock moved $0.164 between high and low, or 1.28%. For the last week the stock has had daily average volatility of 0.98%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (HQL) For The Upcoming Trading Day Of Tuesday 23rd
For the upcoming trading day on Tuesday, 23rd we expect Tekla Life Sciences Investors to open at $12.95, and during the day (based on 14 day Average True Range), to move between $12.83 and $13.15, which gives a possible trading interval of +/-$0.165 (+/-1.27%) up or down from last closing price. If Tekla Life Sciences Investors takes out the full calculated possible swing range there will be an estimated 2.54% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $12.98 (0.12%) than the resistance at $13.63 (4.93%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Tekla Life Sciences Investors stock A Buy?
Tekla Life Sciences Investors holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Current score: -2.065 Sell Candidate Unchanged
Predicted Opening Price for Tekla Life Sciences Investors of Tuesday, April 23, 2024
| Fair opening price April 23, 2024 | Current price |
|---|---|
| $12.95 ( 0.298%) | $12.99 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for HQL
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 13.12 | 0.96 % | |
| R2 | 13.05 | 0.483 % | ||
| R1 | 13.01 | 0.185 % | ||
| Current price: | 12.99 | |||
| Support | S1 | 12.89 | -0.780 % | |
| S2 | 12.85 | -1.08 % | ||
| S3 | 12.79 | -1.56 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 13.90 | 7.01 % | |
| R2 | 13.82 | 6.39 % | ||
| R1 | 13.63 | 4.93 % | ||
| Current price | 12.99 | |||
| Support | S1 | 12.98 | -0.115% | |
| S2 | 12.80 | -1.46% | ||
| S3 | 12.79 | -1.54% |
HQL Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Feb 21, 2024 | Feb 21, 2024 | Mar 28, 2024 | $0.390 | 2.86% |
| 2 | Nov 09, 2023 | Nov 21, 2023 | Jan 10, 2024 | $0.300 | 2.09% |
| 3 | Aug 15, 2023 | Aug 24, 2023 | Sep 29, 2023 | $0.320 | 2.57% |
| 4 | May 15, 2023 | May 24, 2023 | Jun 30, 2023 | $0.320 | 2.36% |
| 5 | Feb 15, 2023 | Feb 24, 2023 | Dec 31, 2018 | $0.330 | 2.18% |
FAQ
Click here for our free guide on how to buy Tekla Life Sciences Investors Stock.
